Home Cart Sign in  
Chemical Structure| 1164462-05-8 Chemical Structure| 1164462-05-8

Structure of TG4-155
CAS No.: 1164462-05-8

Chemical Structure| 1164462-05-8

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

TG4-155 is an effective brain-penetrant selective EP2 receptor antagonist, with a Ki of 9.9 nM. TG4-155 exhibits low nanomolar antagonist activity only against EP2 and DP1 receptors. TG4-155 acts with KB of 2.4 nM for EP2, showing 14-fold selectivity over DP1 receptors and 550-4750-fold selectivity over EP1, EP3, EP4, and IP receptors.

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of TG4-155

CAS No. :1164462-05-8
Formula : C23H26N2O4
M.W : 394.46
SMILES Code : CC1=CC2=C(C=CC=C2)N1CCNC(/C=C/C3=CC(OC)=C(C(OC)=C3)OC)=O
MDL No. :MFCD03829939
InChI Key :YBHUXHFZLMFETJ-MDZDMXLPSA-N
Pubchem ID :5886965

Safety of TG4-155

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H315-H319-H335
Precautionary Statements:P280-P305+P351+P338-P337+P313

Related Pathways of TG4-155

GPCR

Isoform Comparison

Biological Activity

In Vitro:

Cell Line
Concentration Treated Time Description References
C6G cells 10 μM 2 days To evaluate the cytotoxicity of TG4-155, results showed that TG4-155 had no significant cytotoxicity at 10 μM. PMC3558819
PC3 cells 1 μM 24 hours To evaluate the effect of TG4-155 on PC3 cell invasion, results showed that TG4-155 completely prevented butaprost-induced cell invasion. PMC3558819
SH-SY5Y cells 20 µM 24 hours To evaluate the protective effect of TG4-155 on 6-OHDA-induced cytotoxicity, results showed that TG4-155 significantly reduced 6-OHDA-induced cytotoxicity. PMC5573328
Neuro-2a cells 10 or 20 µM 24 hours To evaluate the protective effect of TG4-155 on 6-OHDA-induced cytotoxicity, results showed that TG4-155 significantly reduced 6-OHDA-induced cytotoxicity. PMC5573328
PC3 cells 1 μM 48 hours To evaluate the effect of TG4-155 on PC3 cell proliferation, results showed that TG4-155 significantly inhibited PGE2- or butaprost-induced cell proliferation. PMC3558819

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.54mL

0.51mL

0.25mL

12.68mL

2.54mL

1.27mL

25.35mL

5.07mL

2.54mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2
 

Historical Records

Categories